EBITDA Turns Positive for MAP Pharmaceuticals' Third Quarter
Stock Quote:(NGM:MAPP)
11/13/2009
15.93
-0.09
-0.56%
42,137
EBITDA Turns Positive for MAP Pharmaceuticals' Third Quarter
Last
Price Change
% Chg
Volume
New York, NY, November 13, 2009-Ebitda News reports that EBITDA for MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) for its third quarter ended September 30, 2009 was a positive $22,924,000, compared with a n ... read full story